市場調查報告書
商品編碼
1422162
男性女乳症治療市場 - 成長、未來前景、競爭分析,2023-2031Gynecomastia Procedures Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031 |
預計 2024 年至 2032 年預測期內,男性女乳症手術市場將以 8.5% 的複合年增長率成長。由於男性女乳症發病率上升、治療技術的進步以及對男性美學和身體形象的日益關注等因素,男性女乳症治療市場正在經歷顯著增長。然而,男性女乳症治療的高價格是一個主要障礙。隨著市場的不斷發展,技術的進步和對男性美不斷變化的社會態度正在導致男性女乳症手術成為尋求美容和改善身體形象的患者的安全有效的解決方案。預計將促進
男性女乳症手術市場是由全球男性女乳症病例日益普及所推動的。男性女乳症是一種常見疾病,其特徵是男性乳房組織增大,通常是由荷爾蒙失衡、藥物使用或潛在疾病引起的。由於生活方式的改變、久坐的生活方式和接觸內分泌幹擾物,男性女乳症的發生率正在增加。此外,人們對整容手術認識的提高和恥辱感的減少意味著更多的男性正在尋求男性女乳症的治療。因此,對男性女乳症治療的需求龐大,促進了市場成長。
男性女乳症治療市場的成長受到治療技術進步的影響。多年來,矯正男性女乳症的手術和非手術技術取得了重大創新。抽脂和雷射輔助溶脂等微創手術因其減少的停機時間和更好的美容效果而越來越受歡迎。此外,乳房切除術和皮膚緊緻手術等手術技術也得到了改進,以達到更自然、更美觀的效果。技術進步不僅提高了患者滿意度,還擴大了潛在患者基礎並促進了市場成長。
對男性美和身體形象的日益關注在推動男性女乳症手術的需求方面發揮關鍵作用。近年來,文化發生了轉變,轉向擁抱身體積極性並尋求整容手術來增強自信。此外,男性現在更有可能公開表達自己對美麗的擔憂,並考慮透過整容手術來實現自己想要的體型。男性女乳症手術為男性乳房增大提供了安全有效的解決方案,隨著男性尋求改善外表和身體形象,男性女乳症手術的需求激增。社會對男性美的看法和接受度的變化預計將推動未來幾年的市場成長。
影響男性女乳症治療市場的重要限制因素之一是與這些治療相關的高成本。男性女乳症可以透過手術和非手術來矯正,這兩種手術都相對昂貴。手術費用包括手術費、住院費、麻醉費、術後護理費等,對病人來說是一筆重大的財務投資。此外,抽脂和雷射治療等非手術治療也可能非常昂貴。男性女乳症手術的高成本可能會阻止潛在患者接受治療,從而限制市場成長。然而,醫療保健融資選擇和男性女乳症治療保險範圍的進步預計將在未來解決這一限制。
根據年齡類別,市場分為 18-40 歲和 40 歲以上。40 歲以上消費者群體在 2023 年收入份額最高,預計在 2024-2032 年預測期內也將以最高複合年增長率成長。40歲以上年齡層在男性女乳症市場的主導地位可歸因於荷爾蒙變化、長期危險因子的累積影響、藥物使用、老年人更普遍的健康狀況以及經濟實力的增強。隨著男性年齡的增長,荷爾蒙的變化會增加男性女乳症的風險。由於睪固酮水平下降和身體肥胖增加,老年男性更容易出現男性女乳症。同時,18至40歲的年齡組預計在預測期內也將出現強勁成長。男性女乳症在青春期很常見,此時荷爾蒙波動達到高峰。這個年齡層的特徵是青春期開始,導致男性女乳症的發生率較高。此外,隨著社會對男性女乳症的認知提高,18-40 歲年齡層的人更有可能因男性女乳症問題尋求醫療幹預,這可能會增加市場佔有率。
市場依手術類型分為抽脂和切除手術。2023年,切除手術領域將佔據市場最大的收入份額。如果男性女乳症是由於腺體組織增大而不是脂肪過多引起的,那麼手術切除比抽脂手術更有效。此外,去除腺體組織的手術技術的進步也促進了切除手術的興起。外科醫生現在可以使用複雜而精確的技術,可以更有效地去除腺體組織,同時最大限度地減少疤痕。這些發展增加了患者和外科醫生的信心,他們相信切除手術是一種可行的治療選擇。然而,作為一種比切除手術侵入性較小的手術,抽脂術預計將在 2024 年至 2032 年的預測期內呈現最高成長率。在抽脂過程中,透過小切口插入插管,並吸出多餘的脂肪。與切除手術相比,抽脂術的微創性質通常會導致更小的疤痕、更快的恢復期和更少的術後不適。
就地理細分而言,北美在 2023 年的收入方面領先男性女乳症市場。該地區的主導地位是由於男性美學意識的提高、對整容手術的接受程度不斷提高以及提供男性女乳症治療的熟練醫療保健專業人員的存在。此外,有利的醫療保健政策和整容手術保險進一步支持了北美市場的成長。同時,亞太地區預計在 2024 年至 2032 年預測期內複合年增長率最高。可支配收入的增加、對整容手術文化態度的改變以及醫療旅遊業的不斷發展等因素正在推動該地區男性女乳症手術的採用。此外,亞太地區人口眾多且醫療基礎設施不斷增加,預計將有助於市場的擴張。
男性女乳症治療市場競爭激烈,有幾家大公司在全球營運。市場主要參與者包括Allergan, Inc. AbbVie Inc.、Sientra, Inc.、Bausch Health Companies Inc.、Teva Pharmaceutical Industries Ltd.、Johnson &Johnson Services, Inc.、Cadila Pharmaceuticals Ltd.、Sun Pharmaceuticals Industries Ltd.、Zydus Cadila Healthcare Ltd.、Biochem Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Micro Nova Pharmaceuticals Ltd.、Kee Pharma Ltd.等。這些公司在全球擁有強大的影響力,並提供廣泛的男性女乳症治療選擇。為了保持競爭力,這些公司專注於研究和開發,以改善治療效果、擴大產品組合併提高患者安全。此外,我們正在積極發展策略行銷和合作夥伴關係,以提高市場滲透率並加強我們的全球足跡。截至 2023 年,男性女乳症手術市場正在經歷顯著成長,這些主要參與者正在利用市場機會。展望2024年至2032年的預測期,這些參與者預計將繼續主導市場,並透過不斷的創新和策略舉措推動市場成長。
The gynecomastia procedures market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032. The gynecomastia procedures market has experienced significant growth due to factors such as the rising prevalence of gynecomastia cases, advancements in treatment technologies, and increasing focus on male aesthetics and body image. However, the high cost of gynecomastia procedures poses a significant restraint. As the market continues to evolve, technological advancements and evolving societal attitudes towards male aesthetics are expected to fuel the adoption of gynecomastia procedures as a safe and effective solution for patients seeking cosmetic enhancement and improved body image.
The gynecomastia procedures market has been driven by the increasing prevalence of gynecomastia cases worldwide. Gynecomastia is a common condition characterized by the enlargement of male breast tissue, often resulting from hormonal imbalances, medication use, or underlying medical conditions. With changing lifestyles, sedentary habits, and exposure to endocrine-disrupting substances, the incidence of gynecomastia has been on the rise. Additionally, increasing awareness and reduced stigma associated with cosmetic procedures have encouraged more men to seek treatment for gynecomastia. As a result, there has been a significant demand for gynecomastia procedures, contributing to the growth of the market.
The growth of the gynecomastia procedures market has been influenced by advancements in treatment technologies. Over the years, there have been significant innovations in surgical and non-surgical techniques for gynecomastia correction. Minimally invasive procedures, such as liposuction and laser-assisted lipolysis, have gained popularity due to their reduced downtime and better cosmetic outcomes. Additionally, surgical techniques, such as glandular excision and skin tightening procedures, have been refined to achieve more natural and aesthetically pleasing results. Technological advancements have not only improved patient satisfaction but have also expanded the potential patient pool, contributing to the market's growth.
The increasing focus on male aesthetics and body image has played a significant role in driving the demand for gynecomastia procedures. In recent years, there has been a cultural shift towards embracing body positivity and seeking cosmetic enhancements to boost self-confidence. Men are now more open to discussing their aesthetic concerns and considering cosmetic procedures to achieve their desired physique. Gynecomastia procedures, which provide a safe and effective solution for addressing male breast enlargement, have witnessed a surge in demand as men seek to improve their appearance and body image. This changing societal perception and acceptance of male aesthetics are expected to drive the market's growth in the coming years.
One significant restraint that has affected the gynecomastia procedures market is the high cost associated with these treatments. Gynecomastia correction involves surgical and non-surgical procedures, both of which can be relatively expensive. The cost of surgery includes surgeon fees, hospitalization expenses, anesthesia costs, and post-operative care, making it a significant financial investment for patients. Additionally, non-surgical procedures, such as liposuction and laser treatments, also come with considerable costs. The high cost of gynecomastia procedures may deter some potential patients from seeking treatment, limiting the market's growth. However, advancements in healthcare financing options and insurance coverage for gynecomastia treatments are expected to address this restraint in the future.
Based on age category, the market has been segmented into those aged 18 to 40 and those aged over 40. With the highest revenue share in 2023, the segment of consumers aged 40 and older is also expected to grow at the highest CAGR during the forecast period of 2024 to 2032. The dominance of the over-40 age group in the gynecomastia market can be attributed to hormonal changes, the cumulative effects of risk factors over time, medication use, health conditions prevalent in older individuals, and increased financial capability. Hormonal changes occur in men as they age, which increases their risk of developing gynecomastia. Elderly men are more susceptible to gynecomastia due to the decline in testosterone levels and the increase in body obesity. On the other hand, it is anticipated that the 18-to-40 age group will also experience robust growth over the forecast period. Gynecomastia is common during puberty when hormonal fluctuations are at their zenith. This age group is characterized by the onset of puberty, resulting in a higher incidence of gynecomastia cases. In addition, as societal awareness of gynecomastia increases, individuals in the 18-to-40 age range may be more likely to seek medical intervention for gynecomastia concerns, resulting in a larger market share.
The market has been segmented based on procedure type into liposuction and excision. In 2023, the excision procedure segment held the largest revenue share of the market. In instances where gynecomastia is caused by an enlargement of glandular tissue as opposed to superfluous fat, surgical excision is more effective than liposuction. In addition, advances in surgical techniques for glandular tissue excision have contributed to the growing prominence of excision surgery. Surgeons now have access to refined and accurate techniques that enable more effective glandular tissue removal with minimal scarring. These developments have increased patients' and surgeons' confidence in excision surgery as a viable treatment option. As a less invasive procedure than excision surgery, however, liposuction is anticipated to experience the highest growth rate over the forecast period of 2024 to 2032. Through tiny incisions, cannulas are inserted to suction out excess fat during liposuction. In comparison to excision surgery, the minimally invasive nature of liposuction often results in smaller scars, faster recovery periods, and less post-operative discomfort.
In terms of geographic segmentation, North America was leading the market for gynecomastia in terms of revenues in 2023. The region's dominance can be attributed to the increasing awareness of male aesthetics, greater acceptance of cosmetic procedures, and the presence of skilled healthcare professionals offering gynecomastia treatments. Additionally, favorable healthcare policies and insurance coverage for cosmetic procedures further support the market's growth in North America. Meanwhile, the Asia-Pacific region is anticipated to experience the highest CAGR during the forecast period of 2024 to 2032. Factors such as rising disposable income, changing cultural attitudes towards cosmetic enhancements, and a growing medical tourism industry are driving the adoption of gynecomastia procedures in the region. Moreover, the presence of a large population base and increasing healthcare infrastructure are expected to contribute to the market's expansion in Asia-Pacific.
The gynecomastia procedures market is competitive, with several key players operating in the global landscape. Some of the top players in the market include Allergan, Inc. (AbbVie Inc.), Sientra, Inc., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd and Kee Pharma Ltd. These companies have a strong global presence and offer a wide range of gynecomastia treatment options. To maintain their competitive edge, these players focus on research and development to improve treatment outcomes, expand their product portfolios, and enhance patient safety. Additionally, they actively engage in strategic marketing and partnerships to increase market penetration and strengthen their global footprint. As of 2023, the gynecomastia procedures market has witnessed substantial growth, and these top players have capitalized on market opportunities. Looking ahead to the forecast period from 2024 to 2032, it is expected that these players will continue to dominate the market and drive its growth through continued innovation and strategic initiatives.
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofGynecomastia Procedures market are as follows:
Number of end users and consumption volume, price and value.
Micro and macro environment factors that are currently influencing the Gynecomastia Procedures market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Estimated forecast and market projections up to 2031.
FIG. 10Market Positioning of Key Gynecomastia Procedures Market Players, 2023
FIG. 11Global Gynecomastia Procedures Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032